/PRNewswire/ The global biopharmaceutical analytical testing services market size is estimated to grow by USD 4.67 billion from 2024-2028, according to.
"In March 2023, Agilent Technologies, Inc. (US) acquired e-MSion (US). Through this acquisition, Agilent will integrate the e-MSion's ExD cell into its portfolio of advanced workflows, instruments, and analytical
/PRNewswire/ The biopharmaceutical analytical testing services market is expected to grow by USD 3.45 billion from 2022 to 2027. In addition, the momentum.